메뉴 건너뛰기




Volumn 4, Issue 4, 1998, Pages 1021-1029

Activity of oxaliplatin against human tumor colony-forming units

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; IRINOTECAN; OXALIPLATIN; PACLITAXEL;

EID: 0031895783     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (82)

References (38)
  • 1
    • 0029044491 scopus 로고
    • The chemistry and biology of platinum complexes with the 1,2-diaminocyclohexane carrier ligand
    • Chaney, S. The chemistry and biology of platinum complexes with the 1,2-diaminocyclohexane carrier ligand (Review). Int. J. Oncol., 6: 1291-1305, 1995.
    • (1995) Int. J. Oncol. , vol.6 , pp. 1291-1305
    • Chaney, S.1
  • 2
    • 0017061157 scopus 로고
    • Examination of antitumor activities of platinum complexes of 1,2-diaminocyclohexane isomers
    • Kidani, Y., Inagaki, K., and Tsugagoshi, S. Examination of antitumor activities of platinum complexes of 1,2-diaminocyclohexane isomers. Gann, 67: 921-922, 1976.
    • (1976) Gann , vol.67 , pp. 921-922
    • Kidani, Y.1    Inagaki, K.2    Tsugagoshi, S.3
  • 3
    • 0018245944 scopus 로고
    • Antitumor activity of 1,2-diaminocyclohexane-platinum complexes against sarcoma-180 ascite form
    • Kidani, Y., Inagaki, K., Ligo, M., Hoshi, A., and Kuretani, K. Antitumor activity of 1,2-diaminocyclohexane-platinum complexes against sarcoma-180 ascite form. J. Med. Chem., 21: 1315-1318, 1978.
    • (1978) J. Med. Chem. , vol.21 , pp. 1315-1318
    • Kidani, Y.1    Inagaki, K.2    Ligo, M.3    Hoshi, A.4    Kuretani, K.5
  • 4
    • 0028339337 scopus 로고
    • Antitumor activity of isomeric 1,2-diaminocyclohexane platinum(IV) complexes
    • Siddik, Z. H., al-Baker, S., Thai, G., and Khokhar, A. R. Antitumor activity of isomeric 1,2-diaminocyclohexane platinum(IV) complexes. J. Cancer Res. Clin. Oncol., 120: 409-414, 1994.
    • (1994) J. Cancer Res. Clin. Oncol. , vol.120 , pp. 409-414
    • Siddik, Z.H.1    Al-Baker, S.2    Thai, G.3    Khokhar, A.R.4
  • 5
    • 0000525677 scopus 로고    scopus 로고
    • Comparison of an oxaliplatin-Taxol versus a carboplatin-Taxol regimen in the treatment of the MV-522 human lung tumor xenografts
    • Skou, G., Mangold, G., Dexter, D., and Von Hoff, D. Comparison of an oxaliplatin-Taxol versus a carboplatin-Taxol regimen in the treatment of the MV-522 human lung tumor xenografts. Proc. Am. Assoc. Cancer Res., 37: 375, 1996.
    • (1996) Proc. Am. Assoc. Cancer Res. , vol.37 , pp. 375
    • Skou, G.1    Mangold, G.2    Dexter, D.3    Von Hoff, D.4
  • 6
    • 0030722949 scopus 로고    scopus 로고
    • Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidase synthase inhibitor AG337 in human colon, breast, and ovarian cancers
    • Raymond, E., Buquet-Fagot, Djelloul, C., J., Mester, E., Cvitkovic, C., Louvet, C., and Gespach, C. Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidase synthase inhibitor AG337 in human colon, breast, and ovarian cancers. Anticancer Drugs, 8: 876-885, 1997.
    • (1997) Anticancer Drugs , vol.8 , pp. 876-885
    • Raymond, E.1    Buquet-Fagot2    Djelloul, C.J.3    Mester, E.4    Cvitkovic, C.5    Louvet, C.6    Gespach, C.7
  • 7
    • 0001670580 scopus 로고
    • Report on the pharmacokinetic of oxaliplatin in patients with normal and impaired renal function
    • Bastian, G. Report on the pharmacokinetic of oxaliplatin in patients with normal and impaired renal function. Ann. Oncol., 5: 126, 1994.
    • (1994) Ann. Oncol. , vol.5 , pp. 126
    • Bastian, G.1
  • 9
    • 0027522684 scopus 로고
    • Role of carrier ligand in platinum resistance of human carcinoma cell lines
    • Schmidt, W., and Chaney, S. G. Role of carrier ligand in platinum resistance of human carcinoma cell lines. Cancer Res., 53: 799-805, 1993.
    • (1993) Cancer Res. , vol.53 , pp. 799-805
    • Schmidt, W.1    Chaney, S.G.2
  • 10
    • 0030480849 scopus 로고    scopus 로고
    • Increased gene specific repair of cisplatin induced inter-strand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity
    • Lond.
    • Petersen, L. N., Mamenta, E. L., Stevnsner, T., Chaney, S. G., and Bohr, V. A. Increased gene specific repair of cisplatin induced inter-strand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity. Carcinogenesis (Lond.), 17: 2597-2602, 1996.
    • (1996) Carcinogenesis , vol.17 , pp. 2597-2602
    • Petersen, L.N.1    Mamenta, E.L.2    Stevnsner, T.3    Chaney, S.G.4    Bohr, V.A.5
  • 11
    • 0028304413 scopus 로고
    • Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines
    • Mamenta, E. L., Poma, E. E., Kaufmann, W. K., Delmastro, D. A., Grady, H. L., and Chaney, S. G. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines. Cancer Res., 54: 3500-3505, 1994.
    • (1994) Cancer Res. , vol.54 , pp. 3500-3505
    • Mamenta, E.L.1    Poma, E.E.2    Kaufmann, W.K.3    Delmastro, D.A.4    Grady, H.L.5    Chaney, S.G.6
  • 12
    • 0000460127 scopus 로고    scopus 로고
    • Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel
    • Rixe, O., Ortuzar, W., Alvarez, M., Parker, R., Reed, E., Paull, K., and Fojo, T. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel. Biochem. Pharmacol., 52: 1855-1865, 1996.
    • (1996) Biochem. Pharmacol. , vol.52 , pp. 1855-1865
    • Rixe, O.1    Ortuzar, W.2    Alvarez, M.3    Parker, R.4    Reed, E.5    Paull, K.6    Fojo, T.7
  • 13
    • 0025017307 scopus 로고
    • Effects of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality
    • Page, J. D., Husain, I., Sancar, A., and Chaney, S. G. Effects of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality. Biochemistry, 29: 1016-1024, 1990.
    • (1990) Biochemistry , vol.29 , pp. 1016-1024
    • Page, J.D.1    Husain, I.2    Sancar, A.3    Chaney, S.G.4
  • 14
    • 0001377795 scopus 로고
    • The crystal structure and absolute configurations of the antitumor complexes Pt(oxalato)(1R,2R-cyclohexanediamine) and Pt(malanato)(1R,2R-cyclohexanediamine)
    • Bruk, M. A., Bau, R., Noji, M., Inagaki, K., and Kidani, Y. The crystal structure and absolute configurations of the antitumor complexes Pt(oxalato)(1R,2R-cyclohexanediamine) and Pt(malanato)(1R,2R-cyclohexanediamine). Inorg. Chem. Acta, 92: 279-284, 1984.
    • (1984) Inorg. Chem. Acta , vol.92 , pp. 279-284
    • Bruk, M.A.1    Bau, R.2    Noji, M.3    Inagaki, K.4    Kidani, Y.5
  • 15
    • 0002989164 scopus 로고
    • Tris-[cis-dichloro(1,2-diaminocyclohexane)platinum(II)] hydrate and cis-dibromo(1,2-diaminocyclohexane)platinum(II)
    • Lock, C. J. L., and Pilon, P. Tris-[cis-dichloro(1,2-diaminocyclohexane)platinum(II)] hydrate and cis-dibromo(1,2-diaminocyclohexane)platinum(II). Acta Crystallogr. Sect. B Struct. Sci., B27: 45-49, 1981.
    • (1981) Acta Crystallogr. Sect. B Struct. Sci. , vol.B27 , pp. 45-49
    • Lock, C.J.L.1    Pilon, P.2
  • 18
    • 0027146423 scopus 로고
    • In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin
    • Pendyala, L., and Creaven, P. J. In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin. Cancer Res., 53: 5970-5976, 1993.
    • (1993) Cancer Res. , vol.53 , pp. 5970-5976
    • Pendyala, L.1    Creaven, P.J.2
  • 20
    • 0029968277 scopus 로고    scopus 로고
    • Role of chemotherapy for advanced colorectal cancer: New opportunities
    • Bleiberg, H. Role of chemotherapy for advanced colorectal cancer: new opportunities. Semin. Oncol., 23: 42-50, 1996.
    • (1996) Semin. Oncol. , vol.23 , pp. 42-50
    • Bleiberg, H.1
  • 22
    • 0027310715 scopus 로고
    • Oxaliplatin activity against metastatic colorectal cancer: A Phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate
    • Levi, F., Perpoint, B., Garufi, C., Focan, C., Chollet, P., Depres-Brummer, P., Zidani, R., Brienza, S., Itzhaki, M., Iacobelli, S., et al. Oxaliplatin activity against metastatic colorectal cancer: a Phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate. Eur. J. Cancer, 9: 1280-1284, 1993.
    • (1993) Eur. J. Cancer , vol.9 , pp. 1280-1284
    • Levi, F.1    Perpoint, B.2    Garufi, C.3    Focan, C.4    Chollet, P.5    Depres-Brummer, P.6    Zidani, R.7    Brienza, S.8    Itzhaki, M.9    Iacobelli, S.10
  • 30
    • 0024373787 scopus 로고
    • Antitumor activity of a new platinum complex oxalato (trans-l-1,2-diaminocyclohexane)platinum(II): New experimental data
    • Tashiro, T., Kawada, Y., Sakurai, Y., and Kidani, Y. Antitumor activity of a new platinum complex oxalato (trans-l-1,2-diaminocyclohexane)platinum(II): new experimental data. Biomed. Pharmacother., 43: 251-260, 1989.
    • (1989) Biomed. Pharmacother. , vol.43 , pp. 251-260
    • Tashiro, T.1    Kawada, Y.2    Sakurai, Y.3    Kidani, Y.4
  • 31
    • 0024407292 scopus 로고
    • Oxalato-platinum or l-OHP, a third-generation platinum complex: An experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum
    • Mathe, G., Kidani, Y., Segiguchi, M., Edguchi, M., Fredj, G., Peytavin, G., Misset, J. L., Brienza, S., de Vassal, F., and Chenu, E. Oxalato-platinum or l-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum. Biomed. Pharmacother., 43: 237-250, 1989.
    • (1989) Biomed. Pharmacother. , vol.43 , pp. 237-250
    • Mathe, G.1    Kidani, Y.2    Segiguchi, M.3    Edguchi, M.4    Fredj, G.5    Peytavin, G.6    Misset, J.L.7    Brienza, S.8    De Vassal, F.9    Chenu, E.10
  • 32
    • 0017386903 scopus 로고
    • Synthesis and anti-tumor activities of platinum (II) complexes of 1,2-diaminocyclohexane isomers and their related activities
    • Kidani, Y., Inagaki, K., Saito, R., and Tsukagshi, S. Synthesis and anti-tumor activities of platinum (II) complexes of 1,2-diaminocyclohexane isomers and their related activities. J. Clin. Haematol. Oncol., 7: 197-209, 1977.
    • (1977) J. Clin. Haematol. Oncol. , vol.7 , pp. 197-209
    • Kidani, Y.1    Inagaki, K.2    Saito, R.3    Tsukagshi, S.4
  • 33
    • 0029968277 scopus 로고    scopus 로고
    • Role of chemotherapy for advanced colorectal cancer: New opportunities
    • Bleiberg, H. Role of chemotherapy for advanced colorectal cancer: new opportunities. Semin. Oncol., 23: 42-50, 1996.
    • (1996) Semin. Oncol. , vol.23 , pp. 42-50
    • Bleiberg, H.1
  • 34
    • 0025338285 scopus 로고
    • Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate
    • Caussanel, J. P., Levi, F., Brienza, S., Misset, J. L., Itzhaki, M., Adam, R., Milano, G., Hecquet, B., and Mathe, G. Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate. J. Natl. Cancer Inst., 82: 1046-1050, 1990.
    • (1990) J. Natl. Cancer Inst. , vol.82 , pp. 1046-1050
    • Caussanel, J.P.1    Levi, F.2    Brienza, S.3    Misset, J.L.4    Itzhaki, M.5    Adam, R.6    Milano, G.7    Hecquet, B.8    Mathe, G.9
  • 37
    • 0030198880 scopus 로고    scopus 로고
    • The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin
    • Mello, J. A., Acharya, S., Fishel, R., and Essigann, J. M. The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem. Biol., 3: 579-589, 1996.
    • (1996) Chem. Biol. , vol.3 , pp. 579-589
    • Mello, J.A.1    Acharya, S.2    Fishel, R.3    Essigann, J.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.